Keywords: momenta, first, benefit, obama, plan, push, biogenerics

Momenta could be first to benefit from Obama plan to push for biogenerics

Article | 23 March 2009

Print This

Small US firm Momenta Pharmaceuticals may beat Israel's Teva to become the first company to launch a biogeneric drug in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in